65 related articles for article (PubMed ID: 37314696)
1. Ustekinumab in Hidradenitis Suppurativa: A Systematic Review and Meta-analysis.
Masson R; Seivright J; Grogan T; Atluri S; Hamzavi I; Hogeling M; Shi VY; Hsiao JL
Dermatol Ther (Heidelb); 2024 Jun; ():. PubMed ID: 38907878
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Surgical Deroofing and Carbon Dioxide Laser in Moderate-to-Severe Hidradenitis Suppurativa Patients.
Clark SR; Soti V
Cureus; 2024 Mar; 16(3):e56959. PubMed ID: 38545424
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric Influences on Hidradenitis Suppurativa: A Call for Help.
Shan HD; Huffman SS; Bovill JD; Haffner ZK; Towfighi P; Benedict CD; Evans KK
Arch Plast Surg; 2024 May; 51(3):304-310. PubMed ID: 38737841
[No Abstract] [Full Text] [Related]
4. Characteristics and treatment pathways in pediatric and adult hidradenitis suppurativa: An examination using real world data.
Hardin J; Makadia R; Black S; Lara-Corrales I; Diaz LZ; Kirby JS; DeKlotz CMC
JAAD Int; 2023 Sep; 12():124-132. PubMed ID: 37409312
[TBL] [Abstract][Full Text] [Related]
5. Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies.
Fragoso NM; Masson R; Gillenwater TJ; Shi VY; Hsiao JL
Dermatol Ther (Heidelb); 2023 Aug; 13(8):1661-1697. PubMed ID: 37402031
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variants Associated With Hidradenitis Suppurativa.
Sun Q; Broadaway KA; Edmiston SN; Fajgenbaum K; Miller-Fleming T; Westerkam LL; Melendez-Gonzalez M; Bui H; Blum FR; Levitt B; Lin L; Hao H; Harris KM; Liu Z; Thomas NE; Cox NJ; Li Y; Mohlke KL; Sayed CJ
JAMA Dermatol; 2023 Sep; 159(9):930-938. PubMed ID: 37494057
[TBL] [Abstract][Full Text] [Related]
7. Obstacles to Early Diagnosis and Treatment of Hidradenitis Suppurativa: Current Perspectives on Improving Clinical Management.
Snyder CL; Chen SX; Porter ML
Clin Cosmet Investig Dermatol; 2023; 16():1833-1841. PubMed ID: 37483473
[TBL] [Abstract][Full Text] [Related]
8. Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa-Part II: Procedural and Wound Care Therapies.
Fragoso NM; Masson R; Gillenwater TJ; Shi VY; Hsiao JL
Dermatol Ther (Heidelb); 2023 Aug; 13(8):1699-1720. PubMed ID: 37402030
[TBL] [Abstract][Full Text] [Related]
9. Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study.
Garg A; Geissbühler Y; Houchen E; Choudhary N; Arora D; Vellanki V; Srivastava A; Priyanka ; Darcy J; Richardson C; Kimball AB
Am J Clin Dermatol; 2023 Nov; 24(6):977-990. PubMed ID: 37378875
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine for the treatment of hidradenitis suppurativa.
Brant EG; Akilov O
JAAD Case Rep; 2023 Jul; 37():64-67. PubMed ID: 37332363
[No Abstract] [Full Text] [Related]
11. Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: A phase 2 randomized study.
Kimball AB; Podda M; Alavi A; Miller M; Shen YK; Li S; Xu Y; Han C; Fakharzadeh S; Yang YW; DePrimo S; Munoz E; Chen Y; Passeron T; Papp K
J Eur Acad Dermatol Venereol; 2023 Oct; 37(10):2098-2108. PubMed ID: 37317022
[TBL] [Abstract][Full Text] [Related]
12. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy.
Shanmugam VK; Mulani S; McNish S; Harris S; Buescher T; Amdur R
Int J Dermatol; 2018 Jan; 57(1):62-69. PubMed ID: 29130482
[TBL] [Abstract][Full Text] [Related]
14. Drug Survival of Biologics in Patients With Hidradenitis Suppurativa.
Ring HC; Maul JT; Yao Y; Wu JJ; Thyssen JP; Thomsen SF; Egeberg A
JAMA Dermatol; 2022 Feb; 158(2):184-188. PubMed ID: 34851360
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hidradenitis suppurativa with biologic medications.
Lee RA; Eisen DB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S82-8. PubMed ID: 26470624
[TBL] [Abstract][Full Text] [Related]
16. A safety review of biologic therapies for the management of hidradenitis suppurativa and unmet needs.
Holcomb ZE; Porter ML; Kimball AB
Expert Opin Drug Saf; 2021 Oct; 20(10):1147-1161. PubMed ID: 33910441
[TBL] [Abstract][Full Text] [Related]
17. Effect of Biologics on the Need for Procedural Interventions, Systemic Medications, and Healthcare Utilization in Patients with Hidradenitis Suppurativa: Real-World Data from the UNITE Registry.
Oliveira M; Rahawi K; Duan Y; Lane M; Amin AZ; Sayed CJ
Dermatol Ther (Heidelb); 2023 Jul; 13(7):1577-1585. PubMed ID: 37314696
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
